James J. LaRocca is an assurance partner in the Firm’s Long Island office and a member of its SEC Practice group and its Life Sciences & Biotechnology Industry Group. He brings more than 25 years of experience to audit and business consulting engagements for both closely-held companies and publicly-traded companies, for which he provides financial audits and quarterly review services. Additionally, Mr. LaRocca has assisted his clients in going public through IPOs or reverse capitalization transactions. Mr. LaRocca’s expertise is focused on a variety of industries including biotechnology, software development, securities broker/dealers, Special Purpose Acquisition Companies (SPACs), and telecommunications.